Enzon Pharmaceuticals Inc (ENZN)
0.0755
0.00 (0.00%)
USD |
OTCM |
Nov 14, 15:28
Enzon Pharmaceuticals Total Assets (Quarterly): 47.28M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 47.28M |
| June 30, 2024 | 46.99M |
| March 31, 2024 | 46.83M |
| December 31, 2023 | 47.70M |
| September 30, 2023 | 47.00M |
| June 30, 2023 | 46.67M |
| March 31, 2023 | 46.50M |
| December 31, 2022 | 47.59M |
| September 30, 2022 | 47.26M |
| June 30, 2022 | 47.22M |
| March 31, 2022 | 47.47M |
| December 31, 2021 | 47.75M |
| September 30, 2021 | 47.96M |
| June 30, 2021 | 48.25M |
| March 31, 2021 | 48.29M |
| December 31, 2020 | 48.23M |
| September 30, 2020 | 5.824M |
| June 30, 2020 | 6.004M |
| March 31, 2020 | 6.237M |
| December 31, 2019 | 6.478M |
| September 30, 2019 | 12.07M |
| June 30, 2019 | 12.40M |
| March 31, 2019 | 12.55M |
| December 31, 2018 | 15.51M |
| September 30, 2018 | 8.734M |
| Date | Value |
|---|---|
| June 30, 2018 | 9.01M |
| March 31, 2018 | 9.30M |
| December 31, 2017 | 9.512M |
| September 30, 2017 | 9.053M |
| June 30, 2017 | 15.65M |
| March 31, 2017 | 11.30M |
| December 31, 2016 | 11.27M |
| September 30, 2016 | 21.74M |
| June 30, 2016 | 20.79M |
| March 31, 2016 | 19.86M |
| December 31, 2015 | 22.89M |
| September 30, 2015 | 21.41M |
| June 30, 2015 | 41.29M |
| March 31, 2015 | 37.83M |
| December 31, 2014 | 35.04M |
| September 30, 2014 | 29.32M |
| June 30, 2014 | 21.90M |
| March 31, 2014 | 15.22M |
| December 31, 2013 | 7.121M |
| September 30, 2013 | 22.86M |
| June 30, 2013 | 16.65M |
| March 31, 2013 | 202.30M |
| December 31, 2012 | 199.78M |
| September 30, 2012 | 304.47M |
| June 30, 2012 | 317.05M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
5.824M
Minimum
Sep 2020
48.29M
Maximum
Mar 2021
39.18M
Average
47.24M
Median
Total Assets (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 15.72M |
| Perspective Therapeutics Inc | 385.92M |
| Protalix BioTherapeutics Inc | 91.54M |
| Electromed Inc | 52.23M |
| Armata Pharmaceuticals Inc | 108.31M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 44.51M |
| Shareholders Equity (Quarterly) | 2.762M |